Germany· DE-A57-2f3ca92952996c41
Chinin Orifarm
A quinine product containing quinine sulfate, registered in Germany by Orifarm Healthcare A/S. The same ATC class is registered in 9 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Quinine is registered in 9 of 19 countries.
Countries holding a registration under ATC P01BC01 (quinine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 3 of them publish a price we can compare per daily dose
Quinine · ATC P01BC01
9 / 19 countries
- Canada
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Quinine Sulfate
- Manufacturer
- Orifarm Healthcare A/S
- Country
- Germany (DE)
- ATC code
- P01BC01
- ATC class
- Quinine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
496 interactions on record for quinine.
Graded by severity as the source publishes them — 102 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Quinine · interactions on record
496 records
- 102 severe
- 378 moderate
- 16 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Sodium picosulfateA06AB08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under P01BC01
Quinine, as other registers publish it.
- NetherlandsA-QS 200 Kininesulfaat-dihydraat 200 mg, filmomhulde tablettenACE Pharmaceuticals B.V.
- United StatesChininum sulphuricumBoiron
- United StatesChininum sulphuricumBoiron
- United StatesChininum sulphuricumBoiron
- United StatesChininum sulphuricumBoiron
- United StatesChininum sulphuricumBoiron
- United StatesChininum sulphuricumBoiron
- United StatesChininum SulphuricumHahnemann Laboratories, INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/67cb02f2-a0fa-462d-bc68-a8867552f021 GET /v1/drugs/67cb02f2-a0fa-462d-bc68-a8867552f021?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Quinine Sulfate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about quinine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.